Licensing and Intellectual Property Workshop

Wednesday, June 30th at 9:00-9:45 & 1:30-2:15

This workshop will focus on how companies should prepare their IP for a successful partnering transaction.

Discussion topics:
1. Best practices for building IP.
2. Conducting due diligence investigations.
3. Presenting IP information in a way that best positions that company to its prospective partner.

Through the prism of series of recent transaction examples, the workshop will discuss what worked well and why, as well as mistakes that could have been avoided. Therefore, this workshop would be of keen interest to companies currently involved or contemplating entering into a partnering deal, as well the investment community.

Faculty

Kevin W. McCabe, Director in the Biotechnology/Chemical Group and in the Litigation Group of Sterne, Kessler, Goldstein & Fox PLLC.
He represents clients in complex multi-jurisdiction, multi-party, and multi-patent litigations,including Paragraph IV ANDA litigations. He has argued interference cases before The Board of Patent Appeals and Interferences and has participated in appeals to the Federal Circuit. Mr. McCabe has extensive experience in drafting and prosecuting patent applications in the biotechnology and chemical areas. The patent applications that he has prepared and prosecuted range from medical devices and medical equipment, software, bioinformatics, immunology, microbiology, molecular and cellular biology, biochemistry, immunodiagnostic assays, and therapeutic methods. He has represented a broad range of clients, from Fortune 100 companies and large international conglomerates to non-profit foundations and small start-up companies. In sum, Mr. McCabe is the quintessential renaissance IP lawyer, having gained significant experience across many facets of IP law.